Novacea Inc (NOVC1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael F. Bigham
Employees:
101
75 PARK PLAZA, 4TH FLOOR, BOSTON, MA 02116
(617) 807-6600

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Its products include Omadacycline and Sarecycline. The company was founded in February 2001 and is headquartered in Boston, MA.

Data derived from most recent annual or quarterly report
Market Cap 8.451 Million Shares Outstanding9.39 Million Avg 30-day Volume 59.268 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.19
Price to Revenue5.8932 Debt to Equity-2.4494 EBITDA-74.87 Million
Price to Book Value0.0 Operating Margin-160.907 Enterprise Value400.955 Million
Current Ratio6.852 EPS Growth0.443 Quick Ratio5.882
1 Yr BETA 0.3546 52-week High/Low 0.0 / Profit Margin-205.7391
Operating Cash Flow Growth22.8438 Altman Z-Score-5.9917 Free Cash Flow to Firm -69.636 Million
View SEC Filings from NOVC1 instead.

View recent insider trading info

Novacea Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NOVC1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NOVC1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BIGHAM MICHAEL EXEC. CHAIRMAN OF THE BOARD

  • Officer
  • Director
 922,282 2021-08-16 1

HASKEL WILLIAM M. CLO, GENERAL COUNSEL & SEC.

  • Officer
 370,525 2021-08-16 1

LOH EVAN CEO

  • Officer
  • Director
 1,000,360 2021-08-16 1

WOODROW ADAM PRESIDENT & CHIEF COMMERCIAL

  • Officer
 501,321 2021-08-16 1

BRENNER RANDALL B. CHIEF DEVELOPMENT & REGULATORY

  • Officer
 281,424 2021-08-16 1

FRANSON TIMOTHY R

  • Director
 30,000 2020-02-19 0

STEIN JEFFREY

  • Director
 26,625 2020-02-19 0

PETERSON KRISTINE

  • Director
 30,000 2020-02-19 0

DIETZ THOMAS JOHN

  • Director
 21,000 2020-02-19 0

RADIE ROBERT S

  • Director
 23,250 2020-02-19 0

HOFFMANN ROLF K

  • Director
 35,000 2020-02-19 0

PAGAN DOUGLAS W. CHIEF FINANCIAL OFFICER

  • Officer
 No longer subject to file 2019-04-05 0

BIGHAM MICHAEL CHAIRMAN AND CEO

BIGHAM MICHAEL CHAIRMAN AND CEO

  • Officer
  • Director
 257,167 2018-10-02 1

HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD.

  • 10% Owner
 No longer subject to file 2015-05-28 0

KILEY THOMAS

  • Director
 No longer subject to file 2014-10-30 0

OCLASSEN GLENN A PRESIDENT AND CEO

  • Officer
  • Director
 No longer subject to file 2014-10-30 0

RAAB G KIRK

  • Director
 No longer subject to file 2014-10-30 0

PATTERSON LEONE D VICE PRESIDENT, CFO

  • Officer
 No longer subject to file 2014-10-30 0

LOAR MATTHEW M

  • Director
 No longer subject to file 2014-10-30 0

OMEGA FUND III, L.P.

OMEGA FUND III GP, L.P.

OMEGA FUND III G.P., LTD.

OMEGA FUND IV, L.P.

OMEGA FUND IV GP, L.P.

OMEGA FUND IV G.P. MANAGER, LTD.

OMEGA FUND MANAGEMENT LTD

SIGMA HOLDING LTD

STAMPACCHIA OTELLO

  • 10% Owner
 10,933,503 2014-10-30 0

KOLLINS JOHN A SVP, CHIEF BUSINESS OFFICER

  • Officer
 No longer subject to file 2014-10-30 0

RUEGSEGGER FREDERICK J

  • Director
 No longer subject to file 2014-10-30 0

NUNN JASON RALEIGH

  • Director
 No longer subject to file 2014-10-30 0

SINGH NIKHILESH N SVP & CHIEF SCIENTIFIC OFFICER

  • Officer
 No longer subject to file 2014-10-30 0

BOXMEYER KATHRYN M. SEE REMARKS

  • Officer
 0 2014-10-30 0

K/S DANISH BIOVENTURE

DANISH BIOVENTURE GENERAL PARTNER APS

  • 10% Owner
 1,266,486 2014-10-30 0

LIM RICHARD J.

  • Director
 0 2014-10-30 0

ROUMELL ASSET MANAGEMENT, LLC

  • 10% Owner
 2,207,511 2013-12-13 0

SOLOWAY THOMAS P EVP, CHIEF OPERATING OFFICER

  • Officer
 0 2013-07-15 0

EHRLICH CHRISTOPHER B

  • Director
 0 2013-04-10 0

WORTZMAN MARILYN E VP, FINANCE

  • Officer
 217 2012-04-16 0

LAPORTE KATHLEEN

  • Director
 0 2012-01-24 0

KENNEDY JOSEPH T VP AND GENERAL COUNSEL

  • Officer
 0 2011-12-01 0

INTERWEST PARTNERS IX, LP

ORONSKY ARNOLD L

GIANOS PHILIP T

KLIMAN GILBERT H

CASH HARVEY B

ROSCH THOMAS L

HOLMES W STEPHEN

NASR KHALED

CLEVELAND BRUCE A

PEPPER DOUGLAS A

  • 10% Owner
 1,983,884 2011-09-21 0

INTERWEST MANAGEMENT PARTNERS IX, LLC

KJELLSON NINA S

  • 10% Owner
 1,983,884 2011-09-21 0

NEW LEAF VENTURES I, L.P.

NEW LEAF VENTURE MANAGEMENT I, L.P.

NEW LEAF VENTURE MANAGEMENT I, L.L.C.

CHAMBON PHILIPPE O.

NIEDEL JAMES

LATHI VIJAY K

DELAGARDELLE JEANI

HUNT RONALD

AKKARAJU SRINIVAS

  • FORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNERFORMER 10% BENEFICIAL OWNER
 No longer subject to file 2011-07-18 0

TURNER DANIEL K III

  • Director
 1,099,288 2011-03-29 0

WALKER JOHN PETER

  • Director
 0 2011-02-02 0

SAMUELS CAMILLE D

  • Director
 0 2011-02-02 0

MOORE TERRENCE O VP, MARKETING AND SALES

  • Officer
 3,928 2011-02-02 0

KOPPY SUSAN VP, CORPORATE DEVELOPMENT

  • Officer
 0 2009-02-12 0

NEWHALL CHARLES W III

  • 10% Owner
 2,083,426 2009-01-30 0

KRAMLICH C RICHARD

  • 10% Owner
 2,083,426 2009-01-30 0

BARRIS PETER J

  • 10% Owner
 2,083,426 2009-01-30 0

PERRY MARK W

  • 10% Owner
 2,083,426 2009-01-30 0

NEW ENTERPRISE ASSOCIATES 10 L P

  • 10% Owner
 No longer subject to file 2009-01-30 0

TRAINOR III EUGENE A

  • 10% Owner
 2,083,426 2009-01-30 0

BARRETT M JAMES

  • 10% Owner
 2,083,426 2009-01-30 0

NEA PARTNERS 10 L P

  • 10% Owner
 No longer subject to file 2009-01-30 0

SANDELL SCOTT D

  • 10% Owner
 2,083,426 2009-01-30 0

RAAB MICHAEL

  • Director
 No longer subject to file 2009-01-30 0

TREU JESSE I

  • 10% Owner
 9,289,794 2009-01-28 0

BLAIR JAMES C

  • 10% Owner
 9,289,794 2009-01-28 0

DP V ASSOCIATES LP

  • 10% Owner
 67,875 2009-01-28 0

DOMAIN PARTNERS V LP

  • 10% Owner
 2,907,523 2009-01-28 0

DOVEY BRIAN H

  • 10% Owner
 9,289,794 2009-01-28 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
 9,289,794 2009-01-28 0

ALBINI EDWARD C V.P., CHIEF FINANCIAL OFFICER

  • Officer
 18,897 2008-05-09 0

SINGH AMAR P CHF. COMMERCIALIZATION OFFICER

  • Officer
 8,741 2008-05-09 0

SEARS LOWELL

  • Director
 35,714 2008-02-13 0

HEMBERGER JUDITH A

  • Director
 0 2008-02-13 0

BRADBURY DANIEL

  • Director
 35,714 2008-02-13 0

HEALY JAMES

  • Director
  • 10% Owner
 0 2008-02-13 0

WEBER ECKARD

  • Director
 342,857 2008-02-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments